Natrogen, Takeda deal

Natrogen Therapeutics granted Takeda exclusive, worldwide rights to develop and commercialize Natura-alpha. Takeda also received an exclusive option to acquire Natrogen for an undisclosed amount. Natrogen will receive an undisclosed upfront payment and is eligible for undisclosed regulatory and sales milestones. The company is also eligible for an undisclosed option exercise fee. ...